NCM Capital Management’s Eli Lilly LLY Stock Holding History

NCM Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69M	Sell	2,929 -174	-6%	-$176K	0.96%	20
2025 Q4	$3.34M	Sell	3,103 -140	-4%	-$134K	1.24%	17
2025 Q3	$2.47M	Buy	3,243 +280	+9%	+$208K	0.96%	19
2025 Q2	$2.31M	Sell	2,963 -8	-0.3%	-$6.22K	0.95%	18
2025 Q1	$2.45M	Buy	2,971 +185	+7%	+$154K	1.1%	15
2024 Q4	$2.15M	Buy	2,786 +756	+37%	+$626K	0.97%	18
2024 Q3	$1.8M	Hold	2,030	–	–	0.86%	22
2024 Q2	$1.84M	Sell	2,030 -100	-5%	-$80K	0.96%	20
2024 Q1	$1.66M	Hold	2,130	–	–	0.93%	21
2023 Q4	$1.24M	Buy	2,130 +3	+0.1%	+$1.75K	0.75%	32
2023 Q3	$1.14M	Sell	2,127 -89	-4%	-$45.9K	0.81%	29
2023 Q2	$1.04M	Sell	2,216 -36	-2%	-$15.1K	0.72%	38
2023 Q1	$773K	Hold	2,252	–	–	0.58%	52
2022 Q4	$824K	Hold	2,252	–	–	0.54%	54
2022 Q3	$728K	Hold	2,252	–	–	0.55%	57
2022 Q2	$730K	Buy	2,252 +86	+4%	+$25.8K	0.51%	66
2022 Q1	$620K	Buy	2,166 +1	+0%	+$257	0.39%	86
2021 Q4	$598K	Buy	+2,165	New	+$549K	0.53%	59

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NCM Capital Management's LLY Position: Q1 2026 in Review

NCM Capital Management reduced its Eli Lilly (LLY) stake by 5.6% in Q1 2026, selling an estimated $176K and leaving 2,929 shares worth $2.69M. The position accounts for 0.96% of the portfolio, ranked #20.

NCM Capital Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.34M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

NCM Capital Management held 2,929 shares of Eli Lilly worth $2.69M as of Q1 2026.
NCM Capital Management sold 174 Eli Lilly shares in Q1 2026, an estimated $176K.
Eli Lilly made up 0.96% of NCM Capital Management's portfolio in Q1 2026, its #20 holding.
NCM Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
NCM Capital Management's Eli Lilly position peaked at $3.34M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.